People_

Dr David Tunnicliffe

PhD

Senior Research Fellow, Sydney School of Public Health, The University of Sydney Centre for Kidney Research, The Childrens Hospital at Westmead

Phone

(02) 9845 1470

Email

david.tunnicliffe@sydney.edu.au

Details

Member of Sydney Southeast Asia Centre

Websites

https://ckr.org.au

Related website

Biographical details

Dr David Tunnicliffe was awarded a PhD (medicine) at the Sydney School of Public Health, The University of Sydney in 2018. He is a Senior Research Fellow at the School of Public Health, The University of Sydney based at the Centre for Kidney Research, The Children's Hospital at Westmead. In 2020, David was appointed as the Scientific Director of the Australian and New Zealander clinical practice guidelines organisation (CARI Guidelines). As well, David has a leadership role with Cochrane Kidney and Transplant to provide evidence review for international clinical practice guidelines on kidney disease with Kidney Disease: Improving Global Outcomes (KDIGO). He was awarded a National Health and Medical Research Council Emerging Leadership 1 Investigator Grant (APP1197337) on the implementation and evaluation of living evidence in kidney disease.

Research interests

His research expertise is in quantitative and qualitative evidence synthesis and systematic reviews within the field of kidney disease. He has an interest in improving evidence synthesis methods and processes in the face of the expotential increasing scientific literature to support implementation of research into clinical practice. As well as, improving the dissemination and communication of research findings to people with lived experience of kidney disease.

Teaching and supervision

David is involved in the teaching in the Master of Clinical of Epidemiology, he is a unit of study co-coordinator for CEPI 5315 Introduction to Systematic Review.

Current projects

The development of living guidelines in the management of chronic kidney disease
The translation of living guidelines on chronic kidney disease to consumers
The implementation of clinical practice guidelines on the management of chronic kidney disease among Aboriginal and/or Torres Strait Islanders with kidney disease.
Meta-research in nephrology - The reporting of ethnicity in kidney disease trials, the time-lag between randomised control trial to incoporation into clinical practice guidelines
Application of technology and citizen science to improving systematic reviews and clinical practice guidelines.

Awards and honours

2024 Australian New Zealand Society of Nephrology Mid Career Award Clinical Science.
2024 Faculty of Medicine and Health Mid Career Researcher Outstanding Publication Award.
2017 Finalist Clinical Free Papers Prize, Combined Australian Rheumatology Association and New Zealand Rheumatology Association Annual Scientific Meeting
Best presentation post graduate student, Sydney Musculoskeletal, Bone & Joint Health Alliance, The University of Sydney 1^st scientific meeting, 27^th October 2017
Travel grant – Australian Rheumatology Association Early Career Researcher – American College of Rheumatology/ American Rheumatology Healthcare Professional Annual Meeting 2016, Washington DC, USA
Travel grant – Australian Rheumatology Association – Joint scientific meeting of the New Zealand Rheumatology Association and Australian Rheumatology Association, 2017 Auckland, New Zealand
Travel grant – Australian Paediatric Rheumatology Group, PaediatricSatellite meeting, 2016, Darwin, NT
Travel grant – Australian and New Zealand Society of Nephrology – American Society of Nephrology, Renal Week, 2014, Philadelphia, USA
Travel grant – Australian New Zealand Society of Nephrology, Annual Scientific Meeting, 2014, Melbourne, VIC
Travel grant – Australian New Zealand Society of Nephrology, Annual Scientific Meeting, 2015, Canberra, ACT
Travel grant – Australian New Zealand Society of Nephrology, Annual Scientific Meeting, 2016, Perth, WA

Themes

Obesity, Diabetes and Cardiovascular Disease, Infection and Immunological Conditions

Keywords

Evidence-based medicine, Nephrology, Chronic disease, Evidence synthesis

Approaches

Epidemiology, Qualitative Research, Translational Research

(Cochrane Indonesia) Teaching workshops on qualitative evidence synthesis

Publications

By Type

Expand all

Journals

Tunnicliffe, D., Howell, M., Lee, V., Craig, J. (2025). Improving Transparency and Relevance of the Clinical Practice Guidelines in Nephrology. Kidney International Reports, 10(2), 299-301. [More Information]
Tunnicliffe, D., Reid, S., Craig, J., Samuels, J., Molony, D., Strippoli, G. (2024). Non-immunosuppressive treatment for IgA nephropathy. The Cochrane Library Chichester UK: John Wiley and Sons Ltd, 2024 (2), CD003962. [More Information]
Natale, P., Strippoli, G., Tunnicliffe, D., Toyama, T., Palmer, S., Saglimbene, V., Ruospo, M., Gargano, L., Stallone, G., Gesualdo, L. (2024). Sodium-glucose co-transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes. The Cochrane Library Chichester UK: John Wiley and Sons Ltd, 2024 (5), CD015588. [More Information]
Agarwal, A., Heen, A., Jha, V., Nagler, E., Tunnicliffe, D., Guyatt, G., Vandvik, P., Ponte, B., Agoritsas, T., Zeng, X., et al (2024). Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline. BMJ, , e080257. [More Information]
Cooper, T., Teng, C., Tunnicliffe, D., Cashmore, B., Strippoli, G. (2023). Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease. The Cochrane Library Chichester UK: John Wiley and Sons Ltd, 2023 (7). [More Information]
Arnold-Ujvari, M., Rix, L., Yip, A., Tunnicliffe, D., Kelly, J. (2023). CARI guidelines: Culturally safe and clinical kidney care for First Nations Australians – A summary. Renal Society of Australasia Journal, 19(2), 93-99. [More Information]
Navaneethan, S., Zoungas, S., Caramori, M., Chan, J., Heerspink, H., Liew, A., Michos, E., Olowu, W., Tandon, N., Tuttle, K., Tunnicliffe, D., et al (2023). Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update. Annals of Internal Medicine, 176(3), 381-387. [More Information]
Natale, P., Palmer, S., Tunnicliffe, D., Toyama, T., Strippoli, G. (2023). Dipeptidyl peptidase 4 (DPP-4) inhibitors for people with chronic kidney disease and diabetes. The Cochrane Library Chichester UK: John Wiley and Sons Ltd, 2023 (8), CD015906. [More Information]
Natale, P., Palmer, S., Tunnicliffe, D., Toyama, T., Strippoli, G. (2023). Glucagon-like peptide 1 (GLP-1) receptor agonists for people with chronic kidney disease and diabetes. The Cochrane Library Chichester UK: John Wiley and Sons Ltd, 2023 (4). [More Information]
Cheyne, S., Fraile Navarro, D., Hill, K., McDonald, S., Tunnicliffe, D., White, H., Whittle, S., Karpusheff, J., Mustafa, R., Morgan, R., et al (2023). Methods for living guidelines: early guidance based on practical experience. Journal of Clinical Epidemiology. [More Information]
Fraile Navarro, D., Cheyne, S., Hill, K., McFarlane, E., Morgan, R., Murad, M., Mustafa, R., Sultan, S., Tunnicliffe, D., Vogel, J., et al (2023). Methods for living guidelines: early guidance based on practical experience. Article 5: decisions on methods for evidence synthesis and recommendation development for living guidelines. Journal of Clinical Epidemiology. [More Information]
Cheyne, S., Fraile Navarro, D., Buttery, A., Chakraborty, S., Crane, O., Hill, K., McFarlane, E., Morgan, R., Mustafa, R., Poole, A., Tunnicliffe, D., et al (2023). Methods for living guidelines: early guidance based on practical experience. Paper 3: selecting and prioritizing questions for living guidelines. Journal of Clinical Epidemiology, 155, 73-83. [More Information]
Bateman, S., Riceman, M., Owen, K., Pearson, O., Lester, R., Sinclair, N., McDonald, S., Howell, M., Tunnicliffe, D., Jesudason, S. (2023). Models of care to address disparities in kidney health outcomes for First Nations people. Kidney International, 104(4), 681-689. [More Information]
Raman, G., Tunnicliffe, D., Lai, E., Bennett, T., Caldwell, P. (2023). Safety and tolerability of solifenacin in children and adolescents with overactive bladder- a systematic review. Journal of Pediatric Urology, 19(1), 19.e1-19.e13. [More Information]
Natale, P., Palmer, S., Tunnicliffe, D., Toyama, T., Strippoli, G. (2023). Thiazolidinediones for people with chronic kidney disease and diabetes. The Cochrane Library Chichester UK: John Wiley and Sons Ltd, 2023 (9). [More Information]
Stanley, I., Phoon, R., Toussaint, N., Cullen, V., Kearns, J., Dalbeth, N., Johnson, D., Krishnasamy, R., Tunnicliffe, D. (2022). Caring for Australians and New Zealanders With Kidney Impairment Guidelines: Rapid Development of Urate Lowering Therapy Guidelines for People With CKD. Kidney International Reports, 7(12), 2563-2574. [More Information]
Rovin, B., Glassock, R., Jayne, D., Jha, V., Liew, A., Liu, Z., Meja-Vilet, J., Nester, C., Radhakrishnan, J., Rave, E., Tunnicliffe, D., Howell, M., et al (2022). Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases. Nephrology and Dialysis, 24(1), 21-51. [More Information]
Rossing, P., Caramori, M., Chan, J., Heerspink, H., Khunti, K., Liew, A., Michos, E., Navaneethan, S., Olowu, W., Tandon, N., Tunnicliffe, D., et al (2022). Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence. Kidney International, 102(5), 990-999. [More Information]
Cooper, T., Au, E., Chung, E., Tunnicliffe, D., Craig, J., Gesualdo, L., Howell, M., Mannon, P., Mannon, R., Strippoli, G., Teixeira-Pinto, A., Jaure, A., Wong, G. (2022). Gut microbial biomarkers for predicting adverse outcomes in people with chronic kidney disease. The Cochrane Library Chichester UK: John Wiley and Sons Ltd, 2022 (1), CD014786. [More Information]
Natale, P., Tunnicliffe, D., Saglimbene, V., Toyama, T., Gargano, L., Stallone, G., Ruospo, M., Gesualdo, L., Strippoli, G. (2022). SGLT2 inhibitors for treating diabetes in people with chronic kidney disease. The Cochrane Library Chichester UK: John Wiley and Sons Ltd, 2022 (10). [More Information]
Caramori, M., Tuttle, K., Tandon, N., Tunnicliffe, D., de Boer, I., Rossing, P. (2022). The authors reply. Kidney International, 101(2), 420-421. [More Information]
Sumpton, D., Kelly, A., Tunnicliffe, D., Craig, J., Guha, C., Hassett, G., Jaure, A. (2021). A practical guide to interpreting and applying systematic reviews of qualitative studies in rheumatology. International Journal of Rheumatic Diseases, 24(1), 28-35. [More Information]
Sumpton, D., Hannan, E., Kelly, A., Tunnicliffe, D., Ming, A., Hassett, G., Craig, J., Jaure, A. (2021). Clinicians’ perspectives of shared care of psoriatic arthritis and psoriasis between rheumatology and dermatology: an interview study. Clinical Rheumatology, 40(4), 1369-1380. [More Information]
Mann, J., Chang, T., Cushman, W., Furth, S., Ix, J., Hou, F., Knoll, G., Muntner, P., Pecoits-Filho, R., Sarnak, M., Craig, J., Tunnicliffe, D., Howell, M., et al (2021). Commentary on the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in CKD. Current Cardiology Reports, 23(9), 132. [More Information]
Navaneethan, S., Zoungas, S., Caramori, M., Chan, J., Heerspink, H., Liew, A., Michos, E., Olowu, W., Tandon, N., Tuttle, K., Tunnicliffe, D., Howell, M., et al (2021). Diabetes Management in Chronic Kidney Disease: Synopsis of the 2020 KDIGO Clinical Practice Guideline. Annals of Internal Medicine, 174(3), 385-394. [More Information]
Cheung, A., Chang, T., Cushman, W., Furth, S., Hou, F., Ix, J., Knoll, G., Muntner, P., Pecoits-Filho, R., Sarnak, M., Tunnicliffe, D., Howell, M., et al (2021). Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney International, 99(3), 559-569. [More Information]
Rovin, B., Adler, S., Barratt, J., Bridoux, F., Burdge, K., Chan, T., Cook, H., Fervenza, F., Gibson, K., Glassock, R., Tunnicliffe, D., et al (2021). Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases. Kidney International, 100(4), 753-779. [More Information]
Chong, L., Kerklaan, J., Clarke, S., Kohn, M., Baumgart, A., Guha, C., Tunnicliffe, D., Hanson, C., Craig, J., Jaure, A. (2021). Experiences and Perspectives of Transgender Youths in Accessing Health Care: A Systematic Review. JAMA Pediatrics, 175(11), 1159-1173. [More Information]
von Groote, T., Williams, G., Au, E., Chen, Y., Mathew, A., Hodson, E., Tunnicliffe, D. (2021). Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome. Cochrane Database of Systematic Reviews, 2021 (11), CD004293. [More Information]
Tomson, C., Cheung, A., Mann, J., Chang, T., Cushman, W., Furth, S., Hou, F., Knoll, G., Muntner, P., Pecoits-Filho, R., Tunnicliffe, D., Howell, M., et al (2021). Management of Blood Pressure in Patients With Chronic Kidney Disease Not Receiving Dialysis: Synopsis of the 2021 KDIGO Clinical Practice Guideline. Annals of Internal Medicine, 174(9), 1270-1281. [More Information]
Jiang, I., Major, G., Singh-Grewal, D., Teng, H., Kelly, A., Niddrie, F., Chaitow, J., O’Neill, S., Hassett, G., Damodaran, A., Bernays, S., Manera, K., Jaure, A., Tunnicliffe, D. (2021). Patient and parent perspectives on transition from paediatric to adult healthcare in rheumatic diseases: an interview study. BMJ Open, 11(1), e039670-1-e039670-9. [More Information]
Kelly, A., Tymms, K., Fallon, K., Sumpton, D., Tugwell, P., Tunnicliffe, D., Jaure, A. (2021). Qualitative research in rheumatology: An overview of methods and contributions to practice and policy. Journal of Rheumatology, 48(1), 6-15. [More Information]
Li, S., Vandvik, P., Lytvyn, L., Guyatt, G., Palmer, S., Rodriguez-Gutierrez, R., Foroutan, F., Agoritsas, T., Siemieniuk, R., Walsh, M., Tunnicliffe, D., et al (2021). SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: A clinical practice guideline. BMJ, 373, n1091. [More Information]
Palmer, S., Tendal, B., Mustafa, R., Vandvik, P., Li, S., Hao, Q., Tunnicliffe, D., Ruospo, M., Natale, P., Saglimbene, V., et al (2021). Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: Systematic review and network meta-analysis of randomised controlled trials. BMJ, 372, m4573. [More Information]
de Boer, I., Caramori, M., Chan, J., Heerspink, H., Hurst, C., Khunti, K., Liew, A., Michos, E., Navaneethan, S., Olowu, W., Tunnicliffe, D., Howell, M., et al (2020). Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: evidence-based advances in monitoring and treatment. Kidney International, 98(4), 839-848. [More Information]
Scholes-Robertson, N., Howell, M., Gutman, T., Baumgart, A., Sinka, V., Tunnicliffe, D., May, S., Chalmers, R., Craig, J., Jaure, A. (2020). Patients' and caregivers' perspectives on access to kidney replacement therapy in rural communities: systematic review of qualitative studies. BMJ Open, 10(9), 1-11. [More Information]
Kelly, A., Niddrie, F., Tunnicliffe, D., Matus Gonzalez, A., Hanson, C., Jiang, I., Major, G., Singh-Grewal, D., Tymms, K., Jaure, A. (2020). Patients' attitudes and experiences of transition from paediatric to adult healthcare in rheumatology: a qualitative systematic review. Rheumatology, 59(12), 3737-3750. [More Information]
Sumpton, D., Kelly, A., Tunnicliffe, D., Craig, J., Hassett, G., Chessman, D., Jaure, A. (2020). Patients' perspectives and experience of psoriasis and psoriatic arthritis: a systematic review and thematic synthesis of qualitative studies. Arthritis Care and Research, 72(5), 711-722. [More Information]
Jardine, M., Commons, R., de Zoysa, J., Wong, M., Gilroy, N., Green, J., Henderson, B., Stuart, R., Tunnicliffe, D., van Eps, C., et al (2019). Kidney Health Australia - Caring for Australasians with Renal Impairment guideline recommendations for infection control for haemodialysis units. Nephrology, 24(9), 951-957. [More Information]
Tunnicliffe, D., Palmer, S., Henderson, L., Masson, P., Craig, J., Jaure, A., Singh-Grewal, D., Flanc, R., Roberts, M., Webster, A., Strippoli, G. (2018). Immunosuppressive treatment for proliferative lupus nephritis. Cochrane Database of Systematic Reviews, 6, CD002922. [More Information]
Tunnicliffe, D., Palmer, S. (2018). Immunosuppressive Treatment for Proliferative Lupus Nephritis: Summary of a Cochrane Review. American Journal of Kidney Diseases, 72(5), 756-757. [More Information]
Kelly, A., Tymms, K., Tunnicliffe, D., Sumpton, D., Perera, C., Fallon, K., Craig, J., Abhayaratna, W., Jaure, A. (2018). Patients' attitudes and experiences of disease-modifying antirheumatic drugs in rheumatoid arthritis and spondyloarthritis: A qualitative synthesis. Arthritis Care and Research, 70(4), 525-532. [More Information]
Tunnicliffe, D., Singh-Grewal, D., Craig, J., Jesudason, S., Tugwell, P., Lin, M., O'Neill, S., Sumpton, D., Jaure, A. (2018). Perspectives of Medical Specialists From Different Disciplines on the Management of Systemic Lupus Erythematosus: An Interview Study. Arthritis Care and Research, 70(9), 1284-1293. [More Information]
Tunnicliffe, D., Singh-Grewal, D., Craig, J., Howell, M., Tugwell, P., Mackie, F., Lin, M., O'Neill, S., Ralph, A., Jaure, A. (2017). Healthcare and Research Priorities of Adolescents and Young Adults with Systemic Lupus Erythematosus: A Mixed-methods Study. Journal of Rheumatology, 44(4), 444-451. [More Information]
Miller, H., Jaure, A., Tunnicliffe, D., Campbell, D., Pinter, J., Commons, R., Athan, E., Craig, J., Gilroy, N., Green, J., Howell, M., Wong, M., Jardine, M., et al (2017). Identifying and integrating patient and caregiver perspectives for clinical practice guidelines on the screening and management of infectious microorganisms in hemodialysis units. Hemodialysis International, 21(2), 213-223. [More Information]
Palmer, S., Tunnicliffe, D., Singh-Grewal, D., Mavridis, D., Tonelli, M., Johnson, D., Craig, J., Jaure, A., Strippoli, G. (2017). Induction and Maintenance Immunosuppression Treatment of Proliferative Lupus Nephritis: A Network Meta-analysis of Randomized Trials. American Journal of Kidney Diseases, 70(3), 324-336. [More Information]
Jaure, A., Tunnicliffe, D., Lopez-Vargas, P., Mallett, A., Patel, C., Savige, J., Campbell, K., Patel, M., Tchan, M., Alexander, S., Lee, V., Craig, J., Rangan, G., et al (2016). Identifying and integrating consumer perspectives in clinical practice guidelines on autosomal-dominant polycystic kidney disease. Nephrology, 21(2), 122-132. [More Information]
Rangan, G., Alexander, S., Campbell, K., Dexter, M., Lee, V., Lopez-Vargas, P., Mai, J., Mallett, A., Patel, C., Patel, M., Tchan, M., Jaure, A., Tunnicliffe, D., et al (2016). KHA-CARI guideline recommendations for the diagnosis and management of autosomal dominant polycystic kidney disease. Nephrology, 21(8), 705-716. [More Information]
Tunnicliffe, D., Singh-Grewal, D., Chaitow, J., Mackie, F., Manolios, N., Lin, M., O'Neill, S., Ralph, A., Craig, J., Jaure, A. (2016). Lupus Means Sacrifices: Perspectives of Adolescents and Young Adults with Systemic Lupus Erythematosus. Arthritis Care and Research, 68(6), 828-837. [More Information]
Nakayama, A., Tunnicliffe, D., Thakkar, V., Singh-Grewal, D., O'Neill, S., Craig, J., Jaure, A. (2016). Patients' Perspectives and Experiences Living with Systemic Sclerosis: A Systematic Review and Thematic Synthesis of Qualitative Studies. Journal of Rheumatology, 43(7), 1363-1375. [More Information]
Jaure, A., Rangan, G., Ruospo, M., Saglimbene, V., Strippoli, G., Palmer, S., Tunnicliffe, D., Craig, J. (2015). A painful inheritance-patient perspectives on living with polycystic kidney disease: thematic synthesis of qualitative research. Nephrology, Dialysis, Transplantation, 30(5), 790-800. [More Information]
Rangan, G., Lopez-Vargas, P., Nankivell (Nankievell), B., Tchan, M., Jaure, A., Tunnicliffe, D., Savige, J. (2015). Autosomal Dominant Polycystic Kidney Disease: A Path Forward. Seminars in Nephrology, 35(6), 524-537. [More Information]
Tunnicliffe, D., Singh-Grewal, D., Kim, S., Craig, J., Jaure, A. (2015). Diagnosis, Monitoring, and Treatment of Systemic Lupus Erythematosus: A Systematic Review of Clinical Practice Guidelines. Arthritis Care and Research, 67(10), 1440-1452. [More Information]
Savige, J., Tunnicliffe, D., Rangan, G. (2015). KHA-CARI Autosomal Dominant Kidney Disease Guideline: Management of Chronic Pain. Seminars in Nephrology, 35(6), 607-611.e3. [More Information]
Tchan, M., Savige, J., Patel, C., Mallett, A., Jaure, A., Tunnicliffe, D., Rangan, G. (2015). KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Genetic Testing for Diagnosis. Seminars in Nephrology, 35(6), 545-549.e2. [More Information]
Patel, C., Tchan, M., Savige, J., Mallett, A., Jaure, A., Tunnicliffe, D., Rangan, G. (2015). KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Genetics and Genetic Counseling. Seminars in Nephrology, 35(6), 550-556.e1. [More Information]
Lee, V., Tunnicliffe, D., Rangan, G. (2015). KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Management of End-Stage Kidney Disease. Seminars in Nephrology, 35(6), 595-602.e12. [More Information]
Savige, J., Mallett, A., Tunnicliffe, D., Rangan, G. (2015). KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Management of Polycystic Liver Disease. Seminars in Nephrology, 35(6), 618-622.E5. [More Information]
Mallett, A., Patel, M., Tunnicliffe, D., Rangan, G. (2015). KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Management of Renal Stone Disease. Seminars in Nephrology, 35(6), 603-606 e3. [More Information]
Rangan, G., Lee, V., Alexander, S., Patel, C., Tunnicliffe, D., Vladica, P. (2015). KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Screening for Polycystic Kidney Disease. Seminars in Nephrology, 35(6), 557-564.e6. [More Information]

show 57 more

By Year

Expand all

2025

Tunnicliffe, D., Howell, M., Lee, V., Craig, J. (2025). Improving Transparency and Relevance of the Clinical Practice Guidelines in Nephrology. Kidney International Reports, 10(2), 299-301. [More Information]

2024

Tunnicliffe, D., Reid, S., Craig, J., Samuels, J., Molony, D., Strippoli, G. (2024). Non-immunosuppressive treatment for IgA nephropathy. The Cochrane Library Chichester UK: John Wiley and Sons Ltd, 2024 (2), CD003962. [More Information]
Natale, P., Strippoli, G., Tunnicliffe, D., Toyama, T., Palmer, S., Saglimbene, V., Ruospo, M., Gargano, L., Stallone, G., Gesualdo, L. (2024). Sodium-glucose co-transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes. The Cochrane Library Chichester UK: John Wiley and Sons Ltd, 2024 (5), CD015588. [More Information]
Agarwal, A., Heen, A., Jha, V., Nagler, E., Tunnicliffe, D., Guyatt, G., Vandvik, P., Ponte, B., Agoritsas, T., Zeng, X., et al (2024). Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline. BMJ, , e080257. [More Information]

2023

Cooper, T., Teng, C., Tunnicliffe, D., Cashmore, B., Strippoli, G. (2023). Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease. The Cochrane Library Chichester UK: John Wiley and Sons Ltd, 2023 (7). [More Information]
Arnold-Ujvari, M., Rix, L., Yip, A., Tunnicliffe, D., Kelly, J. (2023). CARI guidelines: Culturally safe and clinical kidney care for First Nations Australians – A summary. Renal Society of Australasia Journal, 19(2), 93-99. [More Information]
Navaneethan, S., Zoungas, S., Caramori, M., Chan, J., Heerspink, H., Liew, A., Michos, E., Olowu, W., Tandon, N., Tuttle, K., Tunnicliffe, D., et al (2023). Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update. Annals of Internal Medicine, 176(3), 381-387. [More Information]
Natale, P., Palmer, S., Tunnicliffe, D., Toyama, T., Strippoli, G. (2023). Dipeptidyl peptidase 4 (DPP-4) inhibitors for people with chronic kidney disease and diabetes. The Cochrane Library Chichester UK: John Wiley and Sons Ltd, 2023 (8), CD015906. [More Information]
Natale, P., Palmer, S., Tunnicliffe, D., Toyama, T., Strippoli, G. (2023). Glucagon-like peptide 1 (GLP-1) receptor agonists for people with chronic kidney disease and diabetes. The Cochrane Library Chichester UK: John Wiley and Sons Ltd, 2023 (4). [More Information]
Cheyne, S., Fraile Navarro, D., Hill, K., McDonald, S., Tunnicliffe, D., White, H., Whittle, S., Karpusheff, J., Mustafa, R., Morgan, R., et al (2023). Methods for living guidelines: early guidance based on practical experience. Journal of Clinical Epidemiology. [More Information]
Fraile Navarro, D., Cheyne, S., Hill, K., McFarlane, E., Morgan, R., Murad, M., Mustafa, R., Sultan, S., Tunnicliffe, D., Vogel, J., et al (2023). Methods for living guidelines: early guidance based on practical experience. Article 5: decisions on methods for evidence synthesis and recommendation development for living guidelines. Journal of Clinical Epidemiology. [More Information]
Cheyne, S., Fraile Navarro, D., Buttery, A., Chakraborty, S., Crane, O., Hill, K., McFarlane, E., Morgan, R., Mustafa, R., Poole, A., Tunnicliffe, D., et al (2023). Methods for living guidelines: early guidance based on practical experience. Paper 3: selecting and prioritizing questions for living guidelines. Journal of Clinical Epidemiology, 155, 73-83. [More Information]
Bateman, S., Riceman, M., Owen, K., Pearson, O., Lester, R., Sinclair, N., McDonald, S., Howell, M., Tunnicliffe, D., Jesudason, S. (2023). Models of care to address disparities in kidney health outcomes for First Nations people. Kidney International, 104(4), 681-689. [More Information]
Raman, G., Tunnicliffe, D., Lai, E., Bennett, T., Caldwell, P. (2023). Safety and tolerability of solifenacin in children and adolescents with overactive bladder- a systematic review. Journal of Pediatric Urology, 19(1), 19.e1-19.e13. [More Information]
Natale, P., Palmer, S., Tunnicliffe, D., Toyama, T., Strippoli, G. (2023). Thiazolidinediones for people with chronic kidney disease and diabetes. The Cochrane Library Chichester UK: John Wiley and Sons Ltd, 2023 (9). [More Information]

show 8 more

2022

Stanley, I., Phoon, R., Toussaint, N., Cullen, V., Kearns, J., Dalbeth, N., Johnson, D., Krishnasamy, R., Tunnicliffe, D. (2022). Caring for Australians and New Zealanders With Kidney Impairment Guidelines: Rapid Development of Urate Lowering Therapy Guidelines for People With CKD. Kidney International Reports, 7(12), 2563-2574. [More Information]
Rovin, B., Glassock, R., Jayne, D., Jha, V., Liew, A., Liu, Z., Meja-Vilet, J., Nester, C., Radhakrishnan, J., Rave, E., Tunnicliffe, D., Howell, M., et al (2022). Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases. Nephrology and Dialysis, 24(1), 21-51. [More Information]
Rossing, P., Caramori, M., Chan, J., Heerspink, H., Khunti, K., Liew, A., Michos, E., Navaneethan, S., Olowu, W., Tandon, N., Tunnicliffe, D., et al (2022). Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence. Kidney International, 102(5), 990-999. [More Information]
Cooper, T., Au, E., Chung, E., Tunnicliffe, D., Craig, J., Gesualdo, L., Howell, M., Mannon, P., Mannon, R., Strippoli, G., Teixeira-Pinto, A., Jaure, A., Wong, G. (2022). Gut microbial biomarkers for predicting adverse outcomes in people with chronic kidney disease. The Cochrane Library Chichester UK: John Wiley and Sons Ltd, 2022 (1), CD014786. [More Information]
Natale, P., Tunnicliffe, D., Saglimbene, V., Toyama, T., Gargano, L., Stallone, G., Ruospo, M., Gesualdo, L., Strippoli, G. (2022). SGLT2 inhibitors for treating diabetes in people with chronic kidney disease. The Cochrane Library Chichester UK: John Wiley and Sons Ltd, 2022 (10). [More Information]
Caramori, M., Tuttle, K., Tandon, N., Tunnicliffe, D., de Boer, I., Rossing, P. (2022). The authors reply. Kidney International, 101(2), 420-421. [More Information]

show 3 more

2021

Sumpton, D., Kelly, A., Tunnicliffe, D., Craig, J., Guha, C., Hassett, G., Jaure, A. (2021). A practical guide to interpreting and applying systematic reviews of qualitative studies in rheumatology. International Journal of Rheumatic Diseases, 24(1), 28-35. [More Information]
Sumpton, D., Hannan, E., Kelly, A., Tunnicliffe, D., Ming, A., Hassett, G., Craig, J., Jaure, A. (2021). Clinicians’ perspectives of shared care of psoriatic arthritis and psoriasis between rheumatology and dermatology: an interview study. Clinical Rheumatology, 40(4), 1369-1380. [More Information]
Mann, J., Chang, T., Cushman, W., Furth, S., Ix, J., Hou, F., Knoll, G., Muntner, P., Pecoits-Filho, R., Sarnak, M., Craig, J., Tunnicliffe, D., Howell, M., et al (2021). Commentary on the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in CKD. Current Cardiology Reports, 23(9), 132. [More Information]
Navaneethan, S., Zoungas, S., Caramori, M., Chan, J., Heerspink, H., Liew, A., Michos, E., Olowu, W., Tandon, N., Tuttle, K., Tunnicliffe, D., Howell, M., et al (2021). Diabetes Management in Chronic Kidney Disease: Synopsis of the 2020 KDIGO Clinical Practice Guideline. Annals of Internal Medicine, 174(3), 385-394. [More Information]
Cheung, A., Chang, T., Cushman, W., Furth, S., Hou, F., Ix, J., Knoll, G., Muntner, P., Pecoits-Filho, R., Sarnak, M., Tunnicliffe, D., Howell, M., et al (2021). Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney International, 99(3), 559-569. [More Information]
Rovin, B., Adler, S., Barratt, J., Bridoux, F., Burdge, K., Chan, T., Cook, H., Fervenza, F., Gibson, K., Glassock, R., Tunnicliffe, D., et al (2021). Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases. Kidney International, 100(4), 753-779. [More Information]
Chong, L., Kerklaan, J., Clarke, S., Kohn, M., Baumgart, A., Guha, C., Tunnicliffe, D., Hanson, C., Craig, J., Jaure, A. (2021). Experiences and Perspectives of Transgender Youths in Accessing Health Care: A Systematic Review. JAMA Pediatrics, 175(11), 1159-1173. [More Information]
von Groote, T., Williams, G., Au, E., Chen, Y., Mathew, A., Hodson, E., Tunnicliffe, D. (2021). Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome. Cochrane Database of Systematic Reviews, 2021 (11), CD004293. [More Information]
Tomson, C., Cheung, A., Mann, J., Chang, T., Cushman, W., Furth, S., Hou, F., Knoll, G., Muntner, P., Pecoits-Filho, R., Tunnicliffe, D., Howell, M., et al (2021). Management of Blood Pressure in Patients With Chronic Kidney Disease Not Receiving Dialysis: Synopsis of the 2021 KDIGO Clinical Practice Guideline. Annals of Internal Medicine, 174(9), 1270-1281. [More Information]
Jiang, I., Major, G., Singh-Grewal, D., Teng, H., Kelly, A., Niddrie, F., Chaitow, J., O’Neill, S., Hassett, G., Damodaran, A., Bernays, S., Manera, K., Jaure, A., Tunnicliffe, D. (2021). Patient and parent perspectives on transition from paediatric to adult healthcare in rheumatic diseases: an interview study. BMJ Open, 11(1), e039670-1-e039670-9. [More Information]
Kelly, A., Tymms, K., Fallon, K., Sumpton, D., Tugwell, P., Tunnicliffe, D., Jaure, A. (2021). Qualitative research in rheumatology: An overview of methods and contributions to practice and policy. Journal of Rheumatology, 48(1), 6-15. [More Information]
Li, S., Vandvik, P., Lytvyn, L., Guyatt, G., Palmer, S., Rodriguez-Gutierrez, R., Foroutan, F., Agoritsas, T., Siemieniuk, R., Walsh, M., Tunnicliffe, D., et al (2021). SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: A clinical practice guideline. BMJ, 373, n1091. [More Information]
Palmer, S., Tendal, B., Mustafa, R., Vandvik, P., Li, S., Hao, Q., Tunnicliffe, D., Ruospo, M., Natale, P., Saglimbene, V., et al (2021). Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: Systematic review and network meta-analysis of randomised controlled trials. BMJ, 372, m4573. [More Information]

show 10 more

2020

de Boer, I., Caramori, M., Chan, J., Heerspink, H., Hurst, C., Khunti, K., Liew, A., Michos, E., Navaneethan, S., Olowu, W., Tunnicliffe, D., Howell, M., et al (2020). Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: evidence-based advances in monitoring and treatment. Kidney International, 98(4), 839-848. [More Information]
Scholes-Robertson, N., Howell, M., Gutman, T., Baumgart, A., Sinka, V., Tunnicliffe, D., May, S., Chalmers, R., Craig, J., Jaure, A. (2020). Patients' and caregivers' perspectives on access to kidney replacement therapy in rural communities: systematic review of qualitative studies. BMJ Open, 10(9), 1-11. [More Information]
Kelly, A., Niddrie, F., Tunnicliffe, D., Matus Gonzalez, A., Hanson, C., Jiang, I., Major, G., Singh-Grewal, D., Tymms, K., Jaure, A. (2020). Patients' attitudes and experiences of transition from paediatric to adult healthcare in rheumatology: a qualitative systematic review. Rheumatology, 59(12), 3737-3750. [More Information]
Sumpton, D., Kelly, A., Tunnicliffe, D., Craig, J., Hassett, G., Chessman, D., Jaure, A. (2020). Patients' perspectives and experience of psoriasis and psoriatic arthritis: a systematic review and thematic synthesis of qualitative studies. Arthritis Care and Research, 72(5), 711-722. [More Information]

show 1 more

2019

Jardine, M., Commons, R., de Zoysa, J., Wong, M., Gilroy, N., Green, J., Henderson, B., Stuart, R., Tunnicliffe, D., van Eps, C., et al (2019). Kidney Health Australia - Caring for Australasians with Renal Impairment guideline recommendations for infection control for haemodialysis units. Nephrology, 24(9), 951-957. [More Information]

2018

Tunnicliffe, D., Palmer, S., Henderson, L., Masson, P., Craig, J., Jaure, A., Singh-Grewal, D., Flanc, R., Roberts, M., Webster, A., Strippoli, G. (2018). Immunosuppressive treatment for proliferative lupus nephritis. Cochrane Database of Systematic Reviews, 6, CD002922. [More Information]
Tunnicliffe, D., Palmer, S. (2018). Immunosuppressive Treatment for Proliferative Lupus Nephritis: Summary of a Cochrane Review. American Journal of Kidney Diseases, 72(5), 756-757. [More Information]
Kelly, A., Tymms, K., Tunnicliffe, D., Sumpton, D., Perera, C., Fallon, K., Craig, J., Abhayaratna, W., Jaure, A. (2018). Patients' attitudes and experiences of disease-modifying antirheumatic drugs in rheumatoid arthritis and spondyloarthritis: A qualitative synthesis. Arthritis Care and Research, 70(4), 525-532. [More Information]
Tunnicliffe, D., Singh-Grewal, D., Craig, J., Jesudason, S., Tugwell, P., Lin, M., O'Neill, S., Sumpton, D., Jaure, A. (2018). Perspectives of Medical Specialists From Different Disciplines on the Management of Systemic Lupus Erythematosus: An Interview Study. Arthritis Care and Research, 70(9), 1284-1293. [More Information]

show 1 more

2017

Tunnicliffe, D., Singh-Grewal, D., Craig, J., Howell, M., Tugwell, P., Mackie, F., Lin, M., O'Neill, S., Ralph, A., Jaure, A. (2017). Healthcare and Research Priorities of Adolescents and Young Adults with Systemic Lupus Erythematosus: A Mixed-methods Study. Journal of Rheumatology, 44(4), 444-451. [More Information]
Miller, H., Jaure, A., Tunnicliffe, D., Campbell, D., Pinter, J., Commons, R., Athan, E., Craig, J., Gilroy, N., Green, J., Howell, M., Wong, M., Jardine, M., et al (2017). Identifying and integrating patient and caregiver perspectives for clinical practice guidelines on the screening and management of infectious microorganisms in hemodialysis units. Hemodialysis International, 21(2), 213-223. [More Information]
Palmer, S., Tunnicliffe, D., Singh-Grewal, D., Mavridis, D., Tonelli, M., Johnson, D., Craig, J., Jaure, A., Strippoli, G. (2017). Induction and Maintenance Immunosuppression Treatment of Proliferative Lupus Nephritis: A Network Meta-analysis of Randomized Trials. American Journal of Kidney Diseases, 70(3), 324-336. [More Information]

2016

Jaure, A., Tunnicliffe, D., Lopez-Vargas, P., Mallett, A., Patel, C., Savige, J., Campbell, K., Patel, M., Tchan, M., Alexander, S., Lee, V., Craig, J., Rangan, G., et al (2016). Identifying and integrating consumer perspectives in clinical practice guidelines on autosomal-dominant polycystic kidney disease. Nephrology, 21(2), 122-132. [More Information]
Rangan, G., Alexander, S., Campbell, K., Dexter, M., Lee, V., Lopez-Vargas, P., Mai, J., Mallett, A., Patel, C., Patel, M., Tchan, M., Jaure, A., Tunnicliffe, D., et al (2016). KHA-CARI guideline recommendations for the diagnosis and management of autosomal dominant polycystic kidney disease. Nephrology, 21(8), 705-716. [More Information]
Tunnicliffe, D., Singh-Grewal, D., Chaitow, J., Mackie, F., Manolios, N., Lin, M., O'Neill, S., Ralph, A., Craig, J., Jaure, A. (2016). Lupus Means Sacrifices: Perspectives of Adolescents and Young Adults with Systemic Lupus Erythematosus. Arthritis Care and Research, 68(6), 828-837. [More Information]
Nakayama, A., Tunnicliffe, D., Thakkar, V., Singh-Grewal, D., O'Neill, S., Craig, J., Jaure, A. (2016). Patients' Perspectives and Experiences Living with Systemic Sclerosis: A Systematic Review and Thematic Synthesis of Qualitative Studies. Journal of Rheumatology, 43(7), 1363-1375. [More Information]

show 1 more

2015

Jaure, A., Rangan, G., Ruospo, M., Saglimbene, V., Strippoli, G., Palmer, S., Tunnicliffe, D., Craig, J. (2015). A painful inheritance-patient perspectives on living with polycystic kidney disease: thematic synthesis of qualitative research. Nephrology, Dialysis, Transplantation, 30(5), 790-800. [More Information]
Rangan, G., Lopez-Vargas, P., Nankivell (Nankievell), B., Tchan, M., Jaure, A., Tunnicliffe, D., Savige, J. (2015). Autosomal Dominant Polycystic Kidney Disease: A Path Forward. Seminars in Nephrology, 35(6), 524-537. [More Information]
Tunnicliffe, D., Singh-Grewal, D., Kim, S., Craig, J., Jaure, A. (2015). Diagnosis, Monitoring, and Treatment of Systemic Lupus Erythematosus: A Systematic Review of Clinical Practice Guidelines. Arthritis Care and Research, 67(10), 1440-1452. [More Information]
Savige, J., Tunnicliffe, D., Rangan, G. (2015). KHA-CARI Autosomal Dominant Kidney Disease Guideline: Management of Chronic Pain. Seminars in Nephrology, 35(6), 607-611.e3. [More Information]
Tchan, M., Savige, J., Patel, C., Mallett, A., Jaure, A., Tunnicliffe, D., Rangan, G. (2015). KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Genetic Testing for Diagnosis. Seminars in Nephrology, 35(6), 545-549.e2. [More Information]
Patel, C., Tchan, M., Savige, J., Mallett, A., Jaure, A., Tunnicliffe, D., Rangan, G. (2015). KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Genetics and Genetic Counseling. Seminars in Nephrology, 35(6), 550-556.e1. [More Information]
Lee, V., Tunnicliffe, D., Rangan, G. (2015). KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Management of End-Stage Kidney Disease. Seminars in Nephrology, 35(6), 595-602.e12. [More Information]
Savige, J., Mallett, A., Tunnicliffe, D., Rangan, G. (2015). KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Management of Polycystic Liver Disease. Seminars in Nephrology, 35(6), 618-622.E5. [More Information]
Mallett, A., Patel, M., Tunnicliffe, D., Rangan, G. (2015). KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Management of Renal Stone Disease. Seminars in Nephrology, 35(6), 603-606 e3. [More Information]
Rangan, G., Lee, V., Alexander, S., Patel, C., Tunnicliffe, D., Vladica, P. (2015). KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Screening for Polycystic Kidney Disease. Seminars in Nephrology, 35(6), 557-564.e6. [More Information]

show 7 more

Selected Grants

2023

Rewarding Research 2024, Tunnicliffe D, Faculty of Medicine and Health/FMH Rewarding Research Success

2021

Delivering next-generation guidelines for kidney disease, Tunnicliffe D, Department of Health and Aged Care (Federal)/Public Health and Chronic Disease Program: Kidney Disease – Key Activities Grant

2020

The implementation and evaluation of living evidence in the management of chronic kidney disease, Tunnicliffe D, National Health and Medical Research Council (NHMRC)/Investigator Grant
Caring for Australians and New Zealanders with Renal Impairment CARI, Tunnicliffe D, Australian and New Zealand society of Nephrology/Research Support

2017

Optimising transition from paediatric to adult healthcare in rheumatology, Tunnicliffe D, Jaure A, Major G, Singh-Grewal D, Arthritis Foundation of Australia/Grants-in-Aid

Page not found

Dr David Tunnicliffe

Publications

By Type

By Year

Selected Grants

2023

2021

2020

2017